In summary, our study well described the complicated regulation of the CXCR2-PI3K/Akt-CD97 signaling pathway, which is positively regulated by IL-8 and serves as the prometastatic factor in ICC progression. The gene discussed is CXCL8; the disease is intrahepatic cholangiocarcinoma.